Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01911819 · ClinicalTrials.gov registry record · NA
A Comparison of Bone Formation With Three Different Bone Graft Materials Following Sinus Graft
A NA study of Inadequate Bone Height in Maxillary Posterior Area, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT01911819 is a NA study of Inadequate Bone Height in Maxillary Posterior Area that has completed, run by Loma Linda University. The registered enrollment target is 22 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01911819, a NA study of Inadequate Bone Height in Maxillary Posterior Area, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare new bone formation following bone graft in sinus using three different commercially available bone graft materials. The study hypothesis is that there is no difference in new bone formation among three bone graft materials under microscope.
Conditions Studied
Interventions
- PROCEDURE Sinus augmentation
- DRUG Equimatrix
- DRUG OSSIF-i sem
- DRUG Bio-oss
Study Locations (1)
California
- Loma Linda University School of Dentistry - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2013-12 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01911819
The ClinicalTrials.gov registry entry for NCT01911819 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Inadequate Bone Height in Maxillary Posterior Area appearing as the primary indexed condition, and to 4 interventions - of which Sinus augmentation is the first listed.
NCT01911819 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01911819 about?
NCT01911819 is a clinical study titled "A Comparison of Bone Formation With Three Different Bone Graft Materials Following Sinus Graft". The purpose of this study is to compare new bone formation following bone graft in sinus using three different commercially available bone graft materials. The study hypothesis is that there is no difference in new bone formation among three bone graft materials under microscope.
What is the current status of trial NCT01911819?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2013-12. Estimated completion is 2016-06.
What conditions does trial NCT01911819 study?
This clinical trial studies the following conditions: Inadequate Bone Height in Maxillary Posterior Area.
What interventions are being tested in trial NCT01911819?
The interventions under investigation include: Sinus augmentation (PROCEDURE), Equimatrix (DRUG), OSSIF-i sem (DRUG), Bio-oss (DRUG).
Who is sponsoring clinical trial NCT01911819?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01911819 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.